Article abstract


Nature Medicine 15, 151 - 158 (2009)
Published online: 1 February 2009 | doi:10.1038/nm.1913

NAMPT is essential for the G-CSF–induced myeloid differentiation via a NAD+–sirtuin-1–dependent pathway

Julia Skokowa1,7, Dan Lan1,6,7, Basant Kumar Thakur1, Fei Wang2, Kshama Gupta1, Gunnar Cario3, Annette Müller Brechlin1, Axel Schambach4, Lars Hinrichsen1, Gustav Meyer5, Matthias Gaestel5, Martin Stanulla1,3, Qiang Tong2 & Karl Welte1


We identified nicotinamide phosphoribosyltransferase (NAMPT), also known as pre-B cell colony enhancing factor (PBEF), as an essential enzyme mediating granulocyte colony-stimulating factor (G-CSF)-triggered granulopoiesis in healthy individuals and in individuals with severe congenital neutropenia. Intracellular NAMPT and NAD+ amounts in myeloid cells, as well as plasma NAMPT and NAD+ levels, were increased by G-CSF treatment of both healthy volunteers and individuals with congenital neutropenia. NAMPT administered both extracellularly and intracellularly induced granulocytic differentiation of CD34+ hematopoietic progenitor cells and of the promyelocytic leukemia cell line HL-60. Treatment of healthy individuals with high doses of vitamin B3 (nicotinamide), a substrate of NAMPT, induced neutrophilic granulocyte differentiation. The molecular events triggered by NAMPT include NAD+-dependent sirtuin-1 activation, subsequent induction of CCAAT/enhancer binding protein-alpha and CCAAT/enhancer binding protein-beta, and, ultimately, upregulation of G-CSF synthesis and G-CSF receptor expression. G-CSF, in turn, further increases NAMPT levels. These results reveal a decisive role of the NAD+ metabolic pathway in G-CSF-triggered myelopoiesis.

Top
  1. Department of Molecular Hematopoiesis, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany.
  2. US Department of Agriculture–Agricultural Research Service, Children's Nutrition Research Center, Baylor College of Medicine, 1100 Bates Street, Houston, Texas 77030, USA.
  3. Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, 24105 Kiel, Germany.
  4. Department of Experimental Hematology, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany.
  5. Department of Biochemistry, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany.
  6. Present address: Department of Pediatrics, the first affiliated Hospital of Guang Xi Medical University, Shuang Yong Road, Guang Xi 530021, China.
  7. These authors contributed equally to this work.

Correspondence to: Karl Welte1 e-mail: Welte.Karl.H@mh-hannover.de

Correspondence to: Julia Skokowa1,7 e-mail: skokowa.julia@mh-hannover.de



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Vitamin B3 boosts neutrophil counts

Nature Medicine News and Views (01 Feb 2009)

Research highlights

Nature Immunology News and Views (01 Feb 2007)

See all 4 matches for News And Views

Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

ADVERTISEMENT